Clinical trial · Observational
Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases
A Randomized, Controlled Trial of Target Therapy Plus Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
NCT01677728CI-TRIAL-00007932unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to explore whether target therapy in combination with chemotherapy as treatment could improve survival or tumor response in patients undergoing Synchronic Hepatectomy for Colorectal Liver Metastases.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Liver Tumor | Liver Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- arm A
- description
- patients received chemotherapy alone
- label
- arm B
- description
- patients received target therapy combined with chemotherapy
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * age between 18 - 75 years old * Performance status (ECOG) 0\~1 * colorectal adenocarcinoma pathologically * without any chemotherapy or radiotherapy * liver metastases undergoing radical resection * colorectal cancer undergoing radical resection * no other metastases * suitable for chemotherapy * agreed by patients Exclusion Criteria: * age below 18 years old or greater than 75 years old * haven't pathological diagnosis of colorectal adenocarcinoma with liver metastase * with any chemotherapy or radiotherapy * with other metastasis * unresectable colorectal cancer or liver metastases * unsuitable for chemotherapy or target therapy * not agreed by patients
References
Publications (0)
Data not yet available
No reference posted for this study.